跳至主要内容
临床试验/ACTRN12619000339156
ACTRN12619000339156已完成未知

A prospective, randomised non-blinded pilot study to optimise oral tranexamic acid dosing in primary total knee arthroplasty

Wesley Medical Research0 个研究点目标入组 35 人开始时间: 2019年3月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • participants of either sex scheduled to undergo a primary, unilateral TKA (either anterior or posterior approach, but not joint resurfacing)
  • - available for follow up at 6 months post-surgery
  • - willingness to provide written, informed consent
  • - willingness to comply with the study

排除标准

  • - known allergy to TXA
  • - acquired disturbances to colour vision
  • - preoperative use of anticoagulants (within 5 days of surgery)
  • - fibrinolytic disorders requiring intraoperative fibrinolytics
  • - coagulopathy, history of arteriolar or venous thromboembolic disease
  • - pregnancy or breastfeeding
  • - hepatic failure
  • - haemoglobin <10g/dL

研究者

相似试验